Elvitegravir (EVG) is an integrase inhibitor developed by Gilead, and approved by the FDA in 2012. It is most commonly administered in combination with cobicistat, FTC (emtricitabine), and tenofovir, a combination that is sold as Stribild.
Found 2 search result(s) for elvitegravir OR EVG.
3.6 John C. Martin — Making it Simpler: A Single Pill to Treat HIV
(HIV/AIDS Research: Its History & Future Meeting)
... rilpivirine to make Complera (TDFFTCrilpivirine) which is broadly available around the world. Then Stribild (elvitegravir (EVG)cobicistatFTC (emtricitabine)tenofovir) more recently—JT (Japan Tobacco) sells our ... ...
Apr 27, 2021
... rilpivirine to make Complera (TDFFTCrilpivirine) which is broadly available around the world. Then Stribild (elvitegravir (EVG)cobicistatFTC (emtricitabine)tenofovir) more recently—JT (Japan Tobacco) sells our ... ...
Apr 27, 2021
cobicistat (Tybost)
(HIV/AIDS Research: Its History & Future Meeting)
... Cobicistat is an HIV treatment that is used in combination with integrase inhibitors, usually elvitegravir. Cobicistat boosts the activity of integrase inhibitors by blocking liver enzymes that would ordinarily ...
Jan 18, 2021
... Cobicistat is an HIV treatment that is used in combination with integrase inhibitors, usually elvitegravir. Cobicistat boosts the activity of integrase inhibitors by blocking liver enzymes that would ordinarily ...
Jan 18, 2021